← Leaderboards
Alexandra Durr
Methodist Hospital Research Institute
$1,196,948
Attributed
$5,984,742
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2018–22$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$5,984,742 · 1
By mechanism
U01$5,984,742 · 1
Top collaborators
- Tetsuo Ashizawa5 shared
- Thomas Klockgether5 shared
- Gulin Oz5 shared
- Henry L Paulson5 shared
Most similar at Methodist Hospital Research Institute
Same institution · by research overlap
- Tetsuo Ashizawa$6,798,395
- Thomas Klockgether$1,196,948
Others in their field
Other Emerging Leaders on “Databases”
- Leonard Freedman · Leidos Biomedical Research, Inc.$186,439,178
- Klaus Romero · Critical Path Institute$90,404,592
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$68,745,882
- Leonard Freedmand · Leidos Biomedical Research, Inc.$50,302,300
- Lynn Briscoe · Leidos Biomedical Research, Inc.$50,165,970
Research focus
DatabasesAnimal DataAnimal ModelBaseBiochemicalAntidepressive AgentsAtaxiaBloodBrain InjuriesCell ModelCerebrospinal FluidCessation Of LifeCitalopramBiological MarkersClinical ResearchBiomedical EngineeringClinical TrialsClinical Trials DesignCodeCohortCohort StudiesCollaborationsComplexDesign
Grant awards (5)
Clinical Trial Readiness for SCA1 and SCA3$1,098,761
U01 · FY2022 · NS
Clinical Trial Readiness for SCA1 and SCA3$1,220,506
U01 · FY2021 · NS
Clinical Trial Readiness for SCA1 and SCA3$1,221,189
U01 · FY2020 · NS
Clinical Trial Readiness for SCA1 and SCA3$1,183,360
U01 · FY2019 · NS
Clinical Trial Readiness for SCA1 and SCA3$1,260,926
U01 · FY2018 · NS